Role of Systemic Immune-Inflammatory Index in Predicting the Development of In-Hospital Malignant Ventricular Arrhythmia in Patients With ST-Elevated Myocardial Infarction
Restricted accessResearch articleFirst published online October, 2023
Role of Systemic Immune-Inflammatory Index in Predicting the Development of In-Hospital Malignant Ventricular Arrhythmia in Patients With ST-Elevated Myocardial Infarction
Many complications can be observed after ST-elevation myocardial infarction (STEMI). The systemic immune-inflammatory index (SII) is a sensitive indicator of the inflammatory state, and this parameter may also be associated with cardiovascular diseases. In this study, we investigated the relationship between malignant ventricular arrhythmias (MVA) development and SII in STEMI patients. A total of 1708 STEMI patients were included in the study. Propensity score matching (PSM) analysis was performed. Patients were divided into 2 groups according to the development of MVA, and predictors of MVA development were investigated. After the PSM analysis, the mean age of 158 patients was 61.6 years, and 68.4% were male. In the univariate analysis, neutrophil count, SII, C-reactive protein (CRP), albumin, and CRP/albumin ratio (CAR) were associated with the development of MVA; while in the regression analysis, CAR and SII was found to be independent predictors of the development of MVA. In this study, we demonstrated that SII is a better independent predictor than other inflammatory parameters for predicting the development of MVA. This index may be useful in clinical use.
ThygesenKAlpertJSJaffeAS, et al.Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618-e651.
2.
IbanezBJamesSAgewallS, et al.2017ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119-177.
3.
RossR. Atherosclerosis--an inflammatory disease. N Engl J Med. 1999;340:115-126.
4.
GeovaniniGRLibbyP. Atherosclerosis and inflammation: Overview and updates. Clin Sci (Lond)2018;132:1243-1252.
5.
ArroyoVGarcia-MartinezRSalvatellaX. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61:396-407.
6.
SprostonNRAshworthJJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754.
7.
KoenigW. High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy. Int J Cardiol. 2013;168:5126-5134.
8.
KurtulAMuratSNYarliogluesM, et al.Usefulness of serum albumin concentration to predict high coronary SYNTAX score and In-hospital mortality in patients with acute coronary syndrome. Angiology. 2016;67:34-40.
9.
PanHCSheuWHLeeWJ, et al.Coronary severity score and C-reactive protein predict major adverse cardiovascular events in patients with stable coronary artery disease (from the Taichung CAD study). Clin Chim Acta. 2015;445:93-100.
10.
BisoendialRJBoekholdtSMVergeerMStroesESKasteleinJJ. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31:2087-2091.
11.
De BackerJMakRDe BacquerD, et al.Parameters of inflammation and infection in a community based case-control study of coronary heart disease. Atherosclerosis. 2002;160:457-463.
12.
SheinenzonAShehadehMMichelisRShaoulERonenO. Serum albumin levels and inflammation. Int J Biol Macromol. 2021;184:857-862.
13.
WangFLiPLiFS. Prognostic role of C-reactive protein to albumin ratio in colorectal cancer: A meta-analysis. Medicine (Baltim). 2019;98:e16064.
14.
ParkJEChungKSSongJH, et al.The C-reactive protein/albumin ratio as a predictor of mortality in critically Ill patients. J Clin Med. 2018;7:333.
15.
BayrakM. Predictive value of C-reactive protein/albumin ratio in patients with chronic complicated diabetes mellitus. Pakistan J Med Sci. 2019;35:1616-1621.
16.
Llop-TalaveronJBadia-TahullMBLeiva-BadosaE. An inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition. Clin Nutr. 2018;37:1575-1583.
17.
LiCTianWZhaoF, et al.Systemic immune-inflammation index, SII, for prognosis of elderly patients with newly diagnosed tumors. Oncotarget. 2018;9:35293-35299.
18.
FengJFChenSYangX. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine (Baltim). 2017;96:e5886.
19.
WangZCJiangWChenXYangLWangHLiuYH. Systemic immune-inflammation index independently predicts poor survival of older adults with hip fracture: A prospective cohort study. BMC Geriatr. 2021;21:155.
20.
DaneshJCollinsRApplebyPPetoR. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA. 1998;279:1477-1482.
21.
DumanHCinierGBakirciEM, et al.Relationship between C-reactive protein to albumin ratio and thrombus Burden in patients with acute coronary Syndrome. Clin Appl Thromb Hemost. 2019;25:1076029618824418.
22.
CinarTCagdasMRencuzogullariI, et al.Prognostic efficacy of C-reactive protein/albumin ratio in ST elevation myocardial infarction. Scand Cardiovasc J. 2019;53:83-90.
23.
AksuUGulcuOAksakalE, et al.The association between CRP/albumin ratio and in-stent restenosis development in patients with ST-segment elevation myocardial infarction. J Clin Lab Anal. 2019;33:e22848.
24.
YangYLWuCHHsuPF, et al.Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50:e13230.
25.
CandemirMKiziltuncENurkocSSahinarslanA. Relationship between systemic immune-inflammation index (SII) and the severity of stable coronary artery disease. Angiology. 2021;72:575-581.
26.
YaltaTYaltaK. Systemic inflammation and arrhythmogenesis: A review of mechanistic and clinical perspectives. Angiology. 2018;69:288-296.
27.
SafranowKDziedziejkoVRzeuskiR, et al.Inflammation markers are associated with metabolic syndrome and ventricular arrhythmia in patients with coronary artery disease. Postepy Hig Med Dosw. 2016;70:56-66.
28.
ElmasEKaelschTWolpertC, et al.Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation. Clin Cardiol. 2006;29:165-169.
29.
BlangyHSadoulNDoussetB, et al.Serum BNP, hs-C-reactive protein, procollagen to assess the risk of ventricular tachycardia in ICD recipients after myocardial infarction. Europace. 2007;9:724-729.
30.
SelcukMCinarTSaylikFDoganSSelcukIOrhanAL. Predictive value of systemic immune inflammation index for postoperative atrial fibrillation in patients undergoing isolated coronary artery bypass grafting. Medeni Med J. 2021;36:318-324.
31.
AtaYAbanozM. Predictive roles of right coronary artery disease severity and systemic immune inflammation index in predicting atrial fibrillation after coronary bypass operations in patients with right coronary artery disease. Heart Surg Forum. 2021;24:E977-E982.
32.
American Diabetes Association Professional Practice C. 2. Classification and diagnosis of diabetes: Standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S17-S38.
33.
JialalIDevarajSVenugopalSK. C-reactive protein: Risk marker or mediator in atherothrombosis?Hypertension. 2004;44:6-11.
34.
SchalkBWVisserMBremmerMAPenninxBWBouterLMDeegDJ. Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal aging study Amsterdam. Am J Epidemiol. 2006;164:969-977.
35.
HorwichTBKalantar-ZadehKMacLellanRWFonarowGC. Albumin levels predict survival in patients with systolic heart failure. Am Heart J. 2008;155:883-889.
36.
MikhailidisDPGanotakisES. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7:125-137.
37.
Seringec AkkececiNYildirim CetinGGogebakanHAcipayamC. The C-Reactive Protein/Albumin Ratio and Complete Blood Count Parameters as Indicators of Disease Activity in Patients with Takayasu Arteritis. Med Sci Monit. 2019;25:1401-1409.
38.
HeinTWSinghUVasquez-VivarJDevarajSKuoLJialalI. Human C-reactive protein induces endothelial dysfunction and uncoupling of eNOS in vivo. Atherosclerosis. 2009;206:61-68.
39.
SadeghiMPourmoghaddasMTavasoliARoohafzaH. Is there any relationship between C-reactive protein level and complex coronary plaques in patients with unstable angina?ARYA Atheroscler. 2010;6:31-34.
40.
NorjaSNuutilaLKarhunenPJGoebelerS. C-reactive protein in vulnerable coronary plaques. J Clin Pathol. 2007;60:545-548.
41.
KarabagYCagdasMRencuzogullariI, et al.Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. J Clin Lab Anal. 2018;32:e22457.
42.
KalyoncuogluMDurmusG. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coron Artery Dis. 2020;31:130-136.
43.
GeXCaoYWangH, et al.Diagnostic accuracy of the postoperative ratio of C-reactive protein to albumin for complications after colorectal surgery. World J Surg Oncol. 2017;15:15.
44.
KimMHAhnJYSongJE, et al.The C-reactive protein/albumin ratio as an independent predictor of mortality in patients with severe sepsis or septic shock treated with early goal-directed therapy. PLoS One. 2015;10:e0132109.
45.
KinoshitaAOnodaHImaiN, et al.The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma. Ann Surg Oncol. 2015;22:803-810.
46.
RanzaniOTZampieriFGForteDNAzevedoLCParkM. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013;8:e59321.
NunezJMinanaGBodiV, et al.Low lymphocyte count and cardiovascular diseases. Curr Med Chem. 2011;18:3226-3233.
49.
GawazMLangerHMayAE. Platelets in inflammation and atherogenesis. J Clin Invest. 2005;115:3378-3384.
50.
HuBYangXRXuY, et al.Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20:6212-6222.
51.
YanQErtaoZZhimeiZ, et al.Systemic immune-inflammation index (SII): A more promising inflammation-based prognostic marker for patients with synchronic colorectal peritoneal carcinomatosis. J Cancer. 2020;11:5264-5272.
52.
WangQZhuSRHuangXPLiuXQLiuJBTianG. Prognostic value of systemic immune-inflammation index in patients with urinary system cancers: A meta-analysis. Eur Rev Med Pharmacol Sci. 2021;25:1302-1310.
53.
WangZ-CJiangWChenXYangLWangHLiuY-H. Systemic immune-inflammation index independently predicts poor survival of older adults with hip fracture: a prospective cohort study. BMC Geriatr. 2021;21:155.
54.
KumbulYÇYasanHMustafaTErdoğanOSivriceMEBüyükcelikBJSTFD. Prognostic evaluation of systemic immune inflammation index in sudden idiopathic sensorineural hearing loss. 2020;27:455-461.
55.
BagciAAksoyF. Systemic immune-inflammation index predicts new-onset atrial fibrillation after ST elevation myocardial infarction. Biomarkers Med. 2021;15:731-739.
56.
OcalLKeskinMCersitS, et al.Systemic immune-inflammation index predicts in-hospital and long-term outcomes in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022 Jun 1;33:251-260.
57.
HayirogluMICinarTCinierG, et al.Evaluating systemic immune-inflammation index in patients with implantable cardioverter defibrillator for heart failure with reduced ejection fraction. Pacing Clin Electrophysiol. 2022;45:188-195.
